Skip to main content
Germany
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkte
  • Über uns
  • Nachrichten
  • Antimikrobielle Resistenz
  • Aidian Academy
  • Expertengespräche
  • Events
  • Apotheken
Kontakt Produkte bestellen Suche
Logo
Kontakt
  • Patientennahe Sofortdiagnostik (POCT)
  • Hygieneüberwachung
  • Mikrobiologie
  • Molecular Dx - microbiology
  • RIA / Kollagene
  • Atemwegsinfektionen
Patientennahe Sofortdiagnostik (POCT)
  • QuikRead go
Weiterlesen
QuikRead go
  • QuikRead go Instrument
  • QuikRead go Plus Instrument
  • QuikRead go CRP
  • QuikRead go easy CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go Zubehör
QuikRead go
Hygieneüberwachung
  • Easicult
  • Hygicult
  • Clean Card PRO
Weiterlesen
Mikrobiologie
  • Uricult Vet
  • Uricult
  • Meridian Immunoassays
  • Meridian Curian®
Weiterlesen
Molecular Dx - microbiology
  • Meridian Revogene®
  • Meridian Alethia®
Weiterlesen
RIA / Kollagene
  • UniQ
Weiterlesen
  • Aidian in Deutschland
  • Vorstand und Management
  • Unternehmenskultur
  • Nachhaltigkeit
  • Karriere
  • Nachrichten
  • Produktnachrichten
  • AMR
  • Veranstaltungen
  • Stories from customers
  • COVID-19
  • Über das C-reaktive Protein (CRP)
  • CRP und Infektionen der unteren Atemwege
  • Weiterführende Informationen
  • QuikRead go CRP-Produkte
  • Verbreitung antibiotikaresistenter Bakterien
  • Nützliche Links
  • Generally
  • Product information
  • Courses
  • Documents and materials
  • Frequently asked questions
  • CRP-Messungen bei Frühchen
  • POC-Tests im Praxisalltag
  • Schlafhygiene: Kontrolle der Sauberkeit von Kissen und Bettbezügen
  • Die Rheuma Bustour
  • POC Testungen in der Apotheke
  • Ein Plus an Service für Ihre Apotheke
  • Was ist ein CRP-Test und wie kann er Ihnen helfen?
  • Was ist ein HbA1c-Test und wie kann er Ihnen helfen?
  • Was ist ein Strep A-Test und wie kann er Ihnen helfen?
Logo
Kontakt Schließen
  • Produkte
    • Patientennahe Sofortdiagnostik (POCT)
      • QuikRead go
    • Hygieneüberwachung
      • Easicult
      • Hygicult
      • Clean Card PRO
    • Mikrobiologie
      • Uricult Vet
      • Uricult
      • Meridian Immunoassays
      • Meridian Curian®
    • Molecular Dx - microbiology
      • Meridian Revogene®
      • Meridian Alethia®
    • RIA / Kollagene
      • UniQ
    • Atemwegsinfektionen
  • Über uns
    • Aidian in Deutschland
    • Vorstand und Management
    • Unternehmenskultur
    • Nachhaltigkeit
    • Karriere
  • Nachrichten
    • Nachrichten
    • Produktnachrichten
    • AMR
    • Veranstaltungen
    • Stories from customers
    • COVID-19
  • Antimikrobielle Resistenz
    • Über das C-reaktive Protein (CRP)
    • CRP und Infektionen der unteren Atemwege
    • Weiterführende Informationen
    • QuikRead go CRP-Produkte
    • Verbreitung antibiotikaresistenter Bakterien
    • Nützliche Links
  • Aidian Academy
    • Generally
    • Product information
    • Courses
    • Documents and materials
    • Frequently asked questions
  • Expertengespräche
    • CRP-Messungen bei Frühchen
    • POC-Tests im Praxisalltag
    • Schlafhygiene: Kontrolle der Sauberkeit von Kissen und Bettbezügen
    • Die Rheuma Bustour
  • Events
  • Apotheken
    • POC Testungen in der Apotheke
    • Ein Plus an Service für Ihre Apotheke
    • Was ist ein CRP-Test und wie kann er Ihnen helfen?
    • Was ist ein HbA1c-Test und wie kann er Ihnen helfen?
    • Was ist ein Strep A-Test und wie kann er Ihnen helfen?
Beliebte Produkte
QuikRead go CRP+Hb

QuikRead go CRP+Hb

QuikRead go Plus Instrument

QuikRead go Plus Instrument

Uricult-Tests

Uricult-Tests

Neuesten Nachrichten
Alle ansehen

Sanova präsentiert den QuikRead go Plus auf dem Pädiatrischen Frühling in Seggau

15. Mai 2025 | Nachrichten, Produktnachrichten

Treffen Sie uns auf dem 32. Bayerischen Hausärztetag in Erlangen

9. Mai 2025 | Nachrichten, Veranstaltungen

Leben retten: Reinigen Sie Ihre Hände

5. Mai 2025 | Nachrichten, Produktnachrichten

  • Alle ansehen
  • keine Ergebnisse gefunden
  • Loading...
Nachrichten

Sanova präsentiert den QuikRead go Plus auf dem Pädiatrischen Frühling in Seggau

15. Mai 2025 | Nachrichten, Produktnachrichten

Treffen Sie uns auf dem 32. Bayerischen Hausärztetag in Erlangen

9. Mai 2025 | Nachrichten, Veranstaltungen

Produkte bestellen
Zurück zu allen Nachrichten
23. August 2022
Nachrichten,
AMR,
COVID-19

COVID-19 pandemic has contributed to the aggravation of Antimicrobial Resistance

Antimicrobial resistance (AMR) is an emerging health threat, but the COVID-19 pandemic set back many actions already combating AMR. Before COVID-19, Antimicrobial stewardship programs and National Actions Plans significantly progressed to slow down Antimicrobial Resistance in many countries. Due to the emergency in the healthcare systems caused by COVID-19, many planned activities were deprioritized and already integrated preventive actions were reversed1,2. For example, antibiotics were prescribed more often without diagnostic confirmation about bacterial infection than before the pandemic1,3.

Recently, the US Centers for Disease Control and Prevention reported that after several years of decrease, antimicrobial resistant hospital-onset infections and deaths increased by at least 15% during the first year of the pandemic. The change in trend indicates that AMR preventive actions must be readdressed and integrated back into the healthcare systems.

Antibiotics were commonly prescribed for hospitalized COVID-19 patients

Antibiotics do not cure viral infections, such as COVID-19, but bacterial co-infections may sometimes accompany viral infections. Treating COVID-19 patients with antibiotics, especially in the early pandemic, seemed to be rather a rule than an exception in many countries. There were concerns about bacterial co-infections, and difficulties in differentiating COVID-19 from community-acquired pneumonia that led excessive antibiotic use. In the USA and China, 80-100% of hospitalized COVID-19 patients received antibiotics1,4. However, bacterial co-infections were reported only on 7-8% of hospitalized and 14% of intensive care patients4, which suggests that antibiotics were often inappropriately used in the treatment of COVID-19.

A person holding a medicine bottle and a pill

The use of broad-spectrum antibiotics increased during COVID-19

In primary care, overall antibiotic consumption decreased in many countries during COVID-19 due to fewer visits to primary care and less spread of respiratory infection. However, the consumption of broad-spectrum antibiotics increased in the EU/EEA countries in both primary care and hospitals.5 Also, in the USA, broad-spectrum antibiotics were commonly used in hospitalized COVID-19 patients1. Broad-spectrum antibiotics are effective against a wide range of bacteria. They are not a first option treatment: they should be used only to treat severe bacterial infections. Therefore, it is necessary to use them correctly to prevent the development of resistance to these drugs.

Immediate actions are needed to optimize antibiotic use and prevent AMR

Now it is more urgent than ever to focus on AMR and reinforce antimicrobial stewardship programs to ensure the appropriate use of antibiotics and other AMR preventive actions in healthcare. Performing fast and accurate point of care tests before antibiotic prescribing, such as QuikRead go CRP and Strep A tests, are an efficient way to optimize antibiotic prescribing and prevent the development of antibiotic resistant bacteria.

Find our portfolio for CRP and Strep A point of care tests from our website: Point of care / QuikRead go


References

  1. Centers of Disease Control and Prevention (CDC). COVID-19: U.S. Impact on Antimicrobial Resistance, Special report 2022. Atlanta, GA: U.S. Department of Health and Human Services. https://www.cdc.gov/drugresistance/pdf/covid19-impact-report-508.pdf
  2. Pan American Health Organization. Antimicrobial Resistance, Fueled by the COVID-19 Pandemic. Policy Brief November 2021. https://iris.paho.org/handle/10665.2/55864
  3. Mantzourani et al. To swab or not to swab? Using point-of-care tests to detect Group A Streptococcus infections as part of a Sore Throat Test and Treat service in community pharmacy. J Antimicrobial Chemoter 2021; 77:803–806.
  4. Lansbury et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81(2):266–275.
  5. Organisation for Economic Co-operation and Development (OECD), European Centre for Disease Control and Prevention (ECDC), European Food Safety Authority (EFSA) and European Medicines Agency (EMA). Briefing note: Antimicrobial Resistance in the EU/EEA: A One Health Response. 2022.
Share
Facebook
Twitter
Email

Aidian Germany GmbH

Papenreye 65
22453 Hamburg


040 5725 7760


Anfragen
info@aidian.de


Verkauf
bestellung@aidian.de

Unternehmen
  • Über uns
  • Nachhaltigkeit
  • Karriere
  • Kontakten Sie uns
  • AGBs
Produkte
  • Patientennahe Sofortdiagnostik (POCT)
  • Hygieneüberwachung
  • Mikrobiologie
  • Molecular Dx - microbiology
  • RIA / Kollagene
  • Atemwegsinfektionen
Quicklinks
  • Aidian Academy
  • Aidian Connect
  • Impressum
Copyright © 2025 Aidian
  • Datenschutz-Bestimmungen
  • Datenschutzerklärung
  • Cookie-Richtlinie
  • Social Media Policy